Treatment delay and outcomes of ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention during the COVID-19 era in South Korea
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Little is known about the clinical characteristics and treatment outcomes of ST-segment elevation myocardial infarction (STEMI) in Korea during the coronavirus disease 2019 (COVID-19) era. We aimed to evaluate the clinical characteristics and treatment outcomes of patients with STEMI in the COVID-19 era. Methods: A total of 588 consecutive patients with STEMI who underwent primary percutaneous coronary intervention were included in this study. The patients were categorized into the COVID-19 (from January 20, 2020 to December 31, 2020) and control groups (from January 20, 2019 to December 31, 2019). Results: The COVID-19 group showed pre-hospital and in-hospital delays than the control group. The control group underwent more thrombus aspiration and had a higher proportion of left main coronary artery diseases, while the COVID-19 group had a higher proportion of multivessel diseases with a marked increase in the number and total length of stents than the control group. As for the prescribed medications, the COVID-19 group was administered more beta-blockers, angiotensin- converting enzyme inhibitors/angiotensin receptor blockers, and statins than the control group. The clinical outcomes were comparable between the groups, except for higher incidences of atrioventricular block and temporary pacemaker implantation in the COVID-19 group. Conclusions: Reperfusion after STEMI treatment during the COVID-19 period was delayed; therefore, efforts should be made to improve on reperfusion.
Abstract
Background/Aims: Little is known about the clinical characteristics and treatment outcomes of ST-segment elevation myocardial infarction (STEMI) in Korea during the coronavirus disease 2019 (COVID-19) era. We aimed to evaluate the clinical characteristics and treatment outcomes of patients with STEMI in the COVID-19 era. Methods: A total of 588 consecutive patients with STEMI who underwent primary percutaneous coronary intervention were included in this study. The patients were categorized into the COVID-19 (from January 20, 2020 to December 31, 2020) and control groups (from January 20, 2019 to December 31, 2019). Results: The COVID-19 group showed pre-hospital and in-hospital delays than the control group. The control group underwent more thrombus aspiration and had a higher proportion of left main coronary artery diseases, while the COVID-19 group had a higher proportion of multivessel diseases with a marked increase in the number and total length of stents than the control group. As for the prescribed medications, the COVID-19 group was administered more beta-blockers, angiotensin- converting enzyme inhibitors/angiotensin receptor blockers, and statins than the control group. The clinical outcomes were comparable between the groups, except for higher incidences of atrioventricular block and temporary pacemaker implantation in the COVID-19 group. Conclusions: Reperfusion after STEMI treatment during the COVID-19 period was delayed; therefore, efforts should be made to improve on reperfusion.
참고문헌 (37)
- Cucinotta D, "WHO declares COVID-19 a pandemic", Acta Biomed, 91, pp.157~160 (2020)
- Kim Yena, "Changing Patterns of Medical Visits and Factors Associated with No-show in Patients with Rheumatoid Arthritis during COVID-19 Pandemic", Journal of Korean Medical Science, 35(48), pp.1~8 (2020), 대한의학회[DOI]
- Sung Ho Kyung, "Impact of the COVID-19 Outbreak on Emergency Care Utilization in Patients with Acute Myocardial Infarction: a Nationwide Population-based Study", Journal of Korean Medical Science, 36(16), pp.1~11 (2021), 대한의학회[DOI]
- Dighe A, "Response to COVID-19 in South Korea and implications for lifting stringent interventions", BMC Med, 18, pp.321~ (2020)
- "COVID-19" (2022)[URL]
- Boserup B, "The impact of the COVID-19 pandemic on emergency department visits and patient safety in the United States", Am J Emerg Med, 38, pp.1732~1736 (2020)
- Kwok CS, "Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction", Heart, 106, pp.1805~1811 (2020)
- Marijon E, "Out-of-hospital cardiac arrest during the COVID-19 pandemic in Paris, France : a population-based, observational study", Lancet Public Health, 5, pp.e437~e443 (2020)
- Lim Daesung, "The Comparison of Emergency Medical Service Responses to and Outcomes of Out-of-hospital Cardiac Arrest before and during the COVID-19 Pandemic in an Area of Korea", Journal of Korean Medical Science, 36(36), pp.1~13 (2021), 대한의학회[DOI]
- Fardman A, "Acute myocardial infarction in the COVID-19 era : incidence, clinical characteristics and in-hospital outcomes : a multicenter registry", PLoS One, 16, pp.e0253524~ (2021)
- Mafham MM, "COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England", Lancet, 396, pp.381~389 (2020)
- Wilson SJ, "Effect of the COVID-19 pandemic on ST-segment-elevation myocardial infarction presentations and in-hospital outcomes", Circ Cardiovasc Interv, 13, pp.e009438~ (2020)
- Bhatt AS, "Fewer hospitalizations for acute cardiovascular conditions during the COVID-19pandemic", J Am Coll Cardiol, 76, pp.280~288 (2020)
- De Rosa S, "Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19era", Eur Heart J, 41, pp.2083~2088 (2020)
- Tam CF, "Impact of coronavirus disease 2019(COVID-19)outbreak on ST-segment-elevation myocardial infarction care in Hong Kong, China", Circ Cardiovasc Qual Outcomes, 13, pp.e006631~ (2020)
- Lidin M, "Patient delay prior to care-seeking in acute myocardial infarction during the outbreak of the coronavirus SARS-CoV2 pandemic", Eur J Cardiovasc Nurs, 20, pp.752~759 (2021)
- Kobayashi S, "Comparison of door-to-balloon time and in-hospital outcomes in patients with ST-elevation myocardial infarction between before versus after COVID-19 pandemic", Cardiovasc Interv Ther (2022)[DOI]
- Ibanez B, "2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation : the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology(ESC)", Eur Heart J, 39, pp.119~177 (2018)
- Collet JP, "2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation", Eur Heart J, 42, pp.1289~1367 (2021)
- Seok Oh, "Long-term outcomes in ST-elevation myocardial infarction patients treated according to hospital visit time", The Korean Journal of Internal Medicine, 37(3), pp.605~617 (2022), 대한내과학회[DOI]
- Lee Unhee, "Source Analysis and Effective Control of a COVID-19 Outbreak in a University Teaching Hospital during a Period of Increasing Community Prevalence of COVID-19", Journal of Korean Medical Science, 36(24), pp.1~13 (2021), 대한의학회[DOI]
- Schlosser M, "COVID-19 testing processes and patient protections for resumption of elective surgery", Am J Surg, 221, pp.49~52 (2021)
- Erol MK, "Treatment delays and in-hospital outcomes in acute myocardial infarction during the COVID-19 pandemic : a nationwide study", Anatol J Cardiol, 24, pp.334~342 (2020)
- Ageta K, "Delay in emergency medical service transportation responsiveness during the COVID-19pandemic in a minimally affected region", Acta Med Okayama, 74, pp.513~520 (2020)
- Satty T, "EMS responses and non-transports during the COVID-19 pandemic", Am J Emerg Med, 42, pp.1~8 (2021)
- Huber K, "COVID-19 : implications for prehospital, emergency and hospital care in patients with acute coronary syndromes", Eur Heart J Acute Cardiovasc Care, 9, pp.222~228 (2020)
- Chew NW, "Impact of the COVID-19pandemic on door-to-balloon time for primary percutaneous coronary intervention : results from the Singapore Western STEMI Network", Circ J, 85, pp.139~149 (2021)
- Gluckman TJ, "Case rates, treatment approaches, and outcomes in acute myocardial infarction during the coronavirus disease 2019 pandemic", JAMA Cardiol, 5, pp.1419~1424 (2020)
- Park J, "Prognostic implications of doorto-balloon time and onset-to-door time on mortality in patients with ST-Segment-elevation myocardial infarction treated with primary percutaneous coronary intervention", J Am Heart Assoc, 8, pp.e012188~ (2019)
- Newby LK, "Cost effectiveness of early discharge after uncomplicated acute myocardial infarction", N Engl J Med, 342, pp.749~755 (2000)
- Mesnier J, "Hospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile in France : a registry study", Lancet Public Health, 5, pp.e536~e542 (2020)
- Kim S, "Discovering spatiotemporal patterns of COVID-19 pandemic in South Korea", Sci Rep, 11, pp.24470~ (2021)
- Seong H, "Comparison of the second and third waves of the COVID-19 pandemic in South Korea : importance of early public health intervention", Int J Infect Dis, 104, pp.742~745 (2021)
- Kim Shin-Woo, "Clinical Characteristics and Outcomes of COVID-19 Cohort Patients in Daegu Metropolitan City Outbreak in 2020", Journal of Korean Medical Science, 36(1), pp.1~15 (2021), 대한의학회[DOI]
- Karim SSA, "Omicron SARS-CoV-2 variant : a new chapter in the COVID-19 pandemic", Lancet, 398, pp.2126~2128 (2021)
- Maslo C, "Characteristics and outcomes of hospitalized patients in South Africa during the COVID-19 Omicron wave compared with previous waves", JAMA, 327, pp.583~584 (2022)
- Del Rio C, "Winter of Omicron : the evolving COVID-19 pandemic", JAMA, 327, pp.319~320 (2022)